Cannabis growers, traders, businesses, researchers, processors, testing laboratory personnel, facility management, and investors, are all invited to attend the SHMC (Southeastern Hemp & Medical Cannabis) Convention being held from the 12th to the 14th of May, 2022, at the Cobb Galleria Centre, Two Galleria Parkway, Atlanta, Georgia. The event, also to be streamed online for worldwide access, is organized by Organa Kannalytics LLC. The SHMC offers a robust platform for startups and industries to identify novel avenues of growth in this dynamic and budding industry. This convention attracts a vast profile of attendees from varied industry verticals seeking investment and business opportunities in the medical cannabis sector. Growing businesses can attain insights from distinguished speakers about the medical advancements, technological breakthroughs, legislative laws, and business prospects of the cannabis industry amidst the growing competition in the Southeastern U.S. region. This forum is all set to witness some of the strongest cannabis players looking to redefine the industry. The emerging hemp and medical cannabis market offers a spectrum of possibilities waiting to be explored. Entrepreneurs, medical practitioners, cultivators, and traders can leverage the mammoth networking scope of this impactful 2-day event to tap the huge cannabis market at their disposal. LUX LEAF Diagnostics, the title sponsor of SHMCC, is a leading testing laboratory dedicated to serving the US market. Sponsors and vendors can set up their individual booths or showcase their products and services. Earlybird discounts are available. Speakers include:

• Tavarres King – King is a veteran player of the National Football League, and CEO of Rowdy Wellness, an Atlanta-based CBD company engaged in the research, education, and development of quality health and wellness products.
• Dallas Austin – Austin is a legendary songwriter, now owner of Rowdy Wellness, and an active cannabis advocate down south

Participants will have access to panel discussions, workshops, speaker sessions on important industry topics, and breaks for building important networking ties. The agenda of the SMHCC is focused on building strong networking contacts for young businesses, as well as educating and creating awareness about the advancement, business scope, and the regulatory local, state, and national legislation relevant to the medical cannabis industry. The team at SHMCC is committed to the safety of the attendees at the physical event and will ensure all health and safety protocols are followed. To learn more, please visit https://www.organakannalytics.com/.

Cannabis entrepreneurs, brand owners, and enthusiasts are all invited to the next edition of BizCann Expo in Medellín, Colombia this May 21-22nd 2022. Having hosted some phenomenal trade shows in numerous cities of the US, BizCann Expo is happy to announce their upcoming event in Medellin, helping local businesses expand and discover global avenues. BizCann Expo is the perfect launchpad for unique business ideas, sharing innovations with industry peers and leaders, as well as discussing the various aspects and strategies for successful cannabis trading. Attendees can showcase their products and services with exhibitors, and those with in depth knowledge of the field can join the show as speakers! This event aims to provide valuable information on the latest cannabis market trends, and offers a huge arena for joint venture collaborations. Participants can enjoy a variety of discussions, keynotes, and workshops. Plus, they’ll be able to find all resources that businesses need to grow and establish themselves in the cannabis industry. Here’s a few other things you can expect:

• Learn about the latest cannabis legislations and attain CLE credits
• Exhibit your talents and services to an enthusiastic audience, for a chance to be discovered by investors
• Explore tactics for maintaining best practices and accounts in your cannabusiness
• New businesses can learn directly from industry leaders at their selection of seminars, talks and panels
• Discover an entire spectrum of resources necessary for kickstarting your cannabis business

To purchase tickets and learn more, please visit www.BizCannExpo.com. BizCann Expo is an 18+ only event. 

Traders, analysts, businesses, and experts in consumer and commercial lending within banks, fintech, and other financial institutions are invited to attend a power-packed virtual session, Finovate Edge: Lendtech, on disruptive digital lending organized by The Finovate Group. The Finovate Group is a premier institution focused on research, analysis, and innovation in financial and banking technology. Get ready to witness cutting-edge insights from the influencers and experts of the digital lending niche, plus, learn and understand the latest industry trends and challenges, all in under 3 hours. The phenomenal bunch of speakers in 2022 includes Curve, Laybuy, Tide, QED Investors, FISPAN, Activant Capital, Home Credit, and more! Discover the best bite-size content on this virtual platform. Attendees can join and interact with their peers and experts anywhere in the world. Some of the attendees include CrossLend, ITF Group JSC, MO Technologies, Currencycloud, Aracar Group, JMMB Express Finance, Federal Reserve Bank of Philadelphia, and more! Greg Palmer, Vice President of Finovate will kick start the event by welcoming the attendees, guest speakers, and more. Some important topics to be covered are:

• Digital analysts will reveal the top digital lending trends to help you understand and build your strategy going forward
• Best practices and things to know before diving into the digital lending process
• Explore real business solutions on how to manage the implementation and succeed in the digital lending space
• Futurist insights on the best moves and risks to avoid to win as a lender
• Become a market leader and learn how to improve the consumer experience as you move ahead in your lending journey
• Future of digital lending and what opportunities can you seize
• Key criteria to effective lending fraud prevention technology
• Embedded lending: Creating a new line of lending techniques for a better consumer experience
• Guide to accessing resources and tips from the risk experts

Participants can join the live show or catch up on-demand later when it suits them. They can ask questions and interact with speakers as well as connect with peers and send them messages. To learn more, please visit https://informaconnect.com/finovate-edge-lendtech.

The Florida Bitcoin & Blockchain Summit hosted by Cutting Edge Events LLC, invites businesses, stakeholders, influencers, regulators, and leaders of the fintech arena, to attend an expansive bitcoin and blockchain event at Hilton Orlando, on May 26-27, 2022. The two-day event will offer expertise on the fast-moving fintech business, explore the blockchain and bitcoin economies in Florida, and discuss important issues in the digital asset space. Cutting Edge Events LLC specializes in hosting hi-tech large-scale events attracting media attention and global acknowledgment. The Florida conference will be graced by industry leaders respected for their many contributions to the fintech space. They will share their insights and views on the future of this evolving modern finance sector. The Florida Bitcoin & Blockchain summit offers a wonderful platform for traders, influencers, and game-changers of the industry, there to actively connect and collaborate. This summit, while focusing on the Florida Bitcoin and Blockchain economy, welcomes global businesses to come together and discuss the prospects of business in the region. These industry stalwarts will guide and educate budding companies about the new financial ecosystem that offers unlimited scope and prospects for placing their bets in the digital finance market. Fintech communities and industry leaders will decide and draw strategies that will put Florida on the center stage for becoming a global leader in cryptocurrency, blockchain, and financial technology. The conference is curated for:

• Beginners- Young entrepreneurs foraying into the fintech space and enthusiasts eager to learn about the fintech and Blockchain investing
• Stakeholders– investors, businesses, capitalists and institutions who want to learn the intricacies of the financial technology trade to invest before others take the plunge
• Advocates– leaders and institutes of the region who want to establish Florida as a leading arena in fintech trade, keeping in mind all laws and regulations of fair trading.

Event organizer Chris Krimitsos, an advocate of the Bitcoin community and the founder of PODFEST, one of the world’s largest podcasting conferences, believes in connecting like-minded people in the industry for networking opportunities that will have a long-term impact. The venue of the event, Hilton Orlando has plush amenities and is centrally located to all the major attractions in the city. The summit offers bitcoin and blockchain traders the opportunity to understand the complexities of the ecosystem, bring the community to a common forum, and derive the maximum business benefits. To learn more, kindly visit https://floridablockchainsummit.com.

• SRAX remains committed to developing tools that empower public companies to thrive in an increasingly challenging business environment
• After successfully building a host of products that help public companies get noticed in the investor community, SRAX is looking into expanding beyond the investor relation space to include cross-organizational tech solutions
• With a business catapulting over the past year, the company has seen a soar in interest from investors with a significant increase in adoption from institutional players

SRAX (NASDAQ: SRAX), a financial technology company that developed Sequire, a software-as-a-service (“SaaS”) platform designed to unlock data and deliver insights for publicly traded companies, appears poised to build upon its growth momentum to expand beyond investor relation space to include integrated cross-organizational solutions that can be deployed across multiple departments, from finance to marketing. As companies struggle to engage investors inundated with an overflow of information, SRAX has recognized that the nature of attracting investors has fundamentally changed in the digital age. The company has made a name for itself as an innovator that helps investor relations teams keep up with the changing needs of the investor community, empowering them with data they can use to create unique shareholder communications campaigns that will set their companies apart in a noisy marketplace. Its unique platform, Sequire, helps companies reach their target audience and increase investor engagement by leveraging a network of more than 9 million active investors. This helps them craft unique media campaigns to target specific communities of investors across social, email, and display platforms. The company continues to go from strength to strength and has grand plans for 2022. In a recent episode of a Sequire Spotlight series called Sequire Spotlight presents SRAX (SRAX): The Savvy Solution to Investor Relations, SRAX’s CEO Christopher Miglino revealed that the product roadmap involves expanding the portfolio to include innovative technology that can be deployed across the whole enterprise (https://ibn.fm/qMHQr). The company appears poised to take its holistic approach beyond the investor relations space to include solutions that are more integrated into the organization, from CFO to marketing. As a technology-centric company committed to building new products fast, SRAX has been working on delivering these new cutting-edge solutions to the marketplace in the months to come. As it continues to deliver strong financial performances quarter after quarter, SRAX has seen increased investor interest with rapid growth in shareholder ownership over the past months. The company started 2021 with around 600,000 shares of institutional ownership to reach more than 7 million shares held by institutional investors. For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

On March 31, 2022, Silo Pharma (OTCQB: SILO) announced an agreement with contract research organization Frontage Laboratories for an Investigational New Drug (“IND”)-enabling, “Pharmacokinetic Study.” Silo merges traditional therapeutics with psychedelic research to relieve patients suffering from PTSD, Alzheimer’s, Parkinson’s, and other rare neurological disorders. Frontage will study Silo’s Central Nervous System Peptide, SPU-16, “a potential new treatment for multiple sclerosis and other conditions,” and their Joint Homing Peptide, SPU-21, used for treating arthritogenic processes, which, according to Silo Pharma CEO Eric Weisblum, could, “enhance the therapeutic effect of current and future therapeutics while decreasing potential systemic toxicity….They may be used to treat both Central Nervous System and Autoimmune Diseases.” Pharmacodynamics studies the reactions between drugs and organisms or, simply, the effect of a drug on the body, allowing for a patient’s existing diseases or conditions, their age and other drugs they’re currently taking. Conversely, pharmacokinetics studies the body’s effect on a drug, its “absorption, distribution, metabolism, and excretion,” or the ways and rates a therapeutic enters, courses through, is modified by and finally exits the system. DMPK (drug metabolism and pharmacokinetics) constitutes a “core discipline in drug development” for assessing drug safety. According to a Frontage Labs factsheet, DMPK studies provide critical research data, assisting therapeutics innovators like Silo to reach important milestones and “decision making during drug discovery and development.” Weisblum says the agreement (with Frontage), “significantly advances our Central Nervous System Peptide, SPU-16, and our Joint Homing Peptide, SPU-21 technologies closer to the clinic.” For a closer look at Pharmacokinetics, check out: The National Library of Medicine, Technology Networks: Drug Discovery, the XenoTech Blog and the Frontage Resource Library. Silo Pharma, headquartered in Englewood Cliffs, New Jersey, identifies assets to license and also funds research to better serve patients and advance the health care industry. Recent achievements include a research agreement with Columbia University developing psychedelic therapeutics for Alzheimer’s disease, DEA approval advancing (with Zylo Therapeutics) Z-Pod technology for delivering time-released Ketamine or Psilocybin, a patent for Silo’s Central Nervous System Homing Peptide, granted by the United States Patent and Trademark Office and a sponsored research agreement with UMB evaluating the pharmacokinetics of dexamethasone delivered to arthritic rats via liposomes. For Silo Pharma’s most recent news, click here. Silo Pharma 560 Sylvan Avenue, Suite 3160 Englewood Cliffs, NJ 07632 For more information, visit the company’s website at www.SiloPharma.com. NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

• There is an accelerating trend to utilize Renewable Natural Gas (“RNG”), including investments by companies big and small to produce RNG from waste to greatly reduce carbon emissions
• Shell has its first U.S. facility in Oregon and agreements to provide RNG to power busses and garbage trucks in Los Angeles
• EverGen Infrastructure Corp. owns Western Canada’s first producing RNG facility and is making acquisitions to ensure its leadership market position in part through a relationship with FortisBC
• EverGen has made its move eastward through a new RNG agreement in Alberta and expects to continue this path with moves into Ontario and Quebec

There may not be a more topical subject today than that of renewable natural gas (“RNG”), an alternative energy product derived from processing feedstocks such as animal waste, crops and crop residue, and food waste. From possible re-routing of global supply chains to implementation of more environmentally friendly energy sources, the world is talking about RNG. Any discussion about RNG in North America needs to include not just industry giants like Shell (NYSE: SHEL), but also upstarts like Vancouver-based EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), as it begins its eastward expansion from its roots in British Columbia. EverGen is focused on combatting climate change and contributing to a sustainable future as an independent renewable energy producer that acquires, develops, builds, owns, and operates a portfolio of RNG, waste-to-energy, and related infrastructure projects. RNG is a relatively straightforward process wherein biogas is made from feedstock via anaerobic digestion, with the biogas then processed into RNG that is injected into the existing natural gas grid for consumption. Any liquid and solid byproducts of the RNG production process can be used for fertilizer or any other multitude of applications. RNG uses abound, including applications in heating and cooling, electricity generation, and fuel for all different types of vehicles, amongst other things. Utilizing RNG solves multiple problems our world faces today, namely reducing carbon emission and responsibly disposing of waste that otherwise would pollute the atmosphere. Companies like EverGen are spearheading mainstream adoption into existing infrastructure with upstream processing solutions. Compared to fossil fuels, renewable compressed natural gas can slash carbon dioxide emissions by 50% to 100%, according to Shell, which has launched its first RNG facility in Junction City, Oregon. The energy juggernaut is committed to the initiative, inking a contract that will result in 20% of Los Angeles Metro’s CNG (compressed natural gas) busses and all the city’s garbage trucks soon to run on Shell RNG. Fact is that while electric vehicles may get all the headlines, RNG is quietly gathering plenty of momentum on its own by creating energy from decomposing organic waste from landfills, food, agriculture and even wastewater treatment plants. EverGen is executing an aggressive growth strategy to capitalize on the RNG trend. The company has made three acquisitions already to cement its position in the market and owns the first producing RNG facility in Western Canada through its Fraser Valley Biogas project (“FVB”). In addition to FVB, EverGen operates two other facilities through its acquired subsidiaries: Net Zero Waste Abbotsford Inc. (“NZWA”) and Sea to Sky Soils and Composting Inc. (“SSS”). EverGen has an important partner/customer in its corner in FortisBC, an electricity and natural gas utility in B.C. valued at CDN$30+ billion. EverGen’s businesses currently have multi-decade agreements in place to supply FortisBC RNG, which puts the upstart alongside a Shell Energy North America (Canada), which supplies FortisBC RNG from a wastewater operation in Iowa. The supply agreements are part of FortisBC’s Clean Growth Pathway to 2050 and aligned with provincial goals to achieve net-zero emissions by 2050. Last month, EverGen made its initial foray into Alberta, signing a letter of intent to acquire a controlling interest (67%) in a biogas facility for CDN$6.6 million in cash and stock. Phase 1 of the project is expected to produce 80,000 gigajoules of RNG annually beginning next quarter with expansion planned to 140,000 gigajoules. A familiar face, FortisBC, is there again agreeing to purchase the RNG for its customers. FortisBC says it is on track to meet or exceed its RNG targets by 2030, which will equate to supplying at least 333,000 homes with carbon-neutral energy, a milestone made possible in part by EverGen, a little company that has its sights set on big things. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

The wait is finally over. Following last year’s rescheduling due to the pandemic, Canada’s premier cannabis event is set for June 1-3rd. On its return to Toronto, the O’Cannabiz International Conference and Expo will feature a VIP Conference, the 3rd annual Awards Gala, and a Retail Summit. To register, visit the following link: https://ocannabiz.com/toronto/register. O’Cannabiz will take place at the International Center in Mississauga, Ontario, Canada. The event is expected to host more than 3,500 attendees and over 180 speakers. The O’Cannabiz VIP Conference is set for June 1st and has a pool of influential speakers such as Derrick Berney, the CEO and Founder of Cannabis Wiki, and Donna Johannson, the Founder and Design Executive of Canadian Women in Cannabis (“CWIC”). Attendees will also have the opportunity to watch a Cooking Demo with Chef Pat Newton and Justin Renfrow. The O’Cannabiz Industry Awards Gala will feature over 50 awards in 5 different categories to honor the top performing cannabis professionals and companies. The event is set for June 1st, 6:15 pm to 9 pm at Casa Loma – Toronto. There will be a 45-minute Red Carpet Royalty Cocktail Reception before commencing the dinner and awards session from 7 pm to 9 pm. Gerry Dee, Host of Family Feud Canada, will host the Awards Dinner Gala. VIP delegates, exhibitors, and sponsors will be treated to a lavish VIP Networking After Party from 9 pm to 11 pm at The Glass Pavilion, Casa Loma. A 2-day Retail Summit and Expo will happen from June 2-3rd. The Retail Summit will be a training program focusing on the needs and goals of cannabis retailers. During this period, exhibitors will showcase their products and solutions in a 50,000 SQ. FT. Expo Hall. The Retail Summit and Expo will be an excellent opportunity for retailers to network and learn about cannabis retail success solutions. Visit the O’Cannabiz website to learn more about this year’s event and purchase tickets: https://ocannabiz.com/

• Hearing loss is affecting a large number of people, and the number is only to increase with the aging population
• Still, many don’t wear hearing aids as they are expensive, often clunky, and inconvenient to get
• INND continues to solve these pain points, empowering consumers to take control of their hearing health with its unique top-quality Direct-to-Consumer (“DTC”) hearing aids

A study published in the journal Archives of Internal Medicine reports that 86% of Americans over 50 with hearing loss don’t wear hearing aids (https://ibn.fm/9aHNd). Hearing aids are costly, getting them can be a cumbersome process, and wearing them can feel stigmatizing. But innovative DTC (soon-to-offered Over-the-Counter (“OTC”) at local pharmacies and Big-Box retailers) hearing aid options delivered by companies such as InnerScope Hearing Technologies (OTC: INND) solve these patients’ pain points. They are lower-priced, as small as a wireless earbud, and easy to get. The price of traditional hearing aids starts from around $1,000, but it can go as high as $14,000 per pair. Most insurance plans provide only fractional coverage, while Medicare doesn’t cover them at all. With a relatively short lifespan of just five to six years on average, the cost burden of traditional hearing aids is significant for many since a patient diagnosed with hearing impairment in their mid-50s will need multiple pairs over their lifetime. Adding to the problem is that access to audiologists can pose another significant obstacle as patients are often required to visit hearing professionals’ numerous times before getting hearing aids. Also, regular rechecks are needed – sometimes as often as every six months – which for many is not sustainable. Still, leaving patients without needed hearing support should not be an option from a medical standpoint. It can pose a risk to their general health since hearing aids are much more than devices that improve hearing. Evidence is amassing that untreated hearing loss is linked to other serious health problems such as depression, cognitive decline, and possibly dementia (https://ibn.fm/zxnD8). Without them, patients often suffer from low confidence, poor self-image, and deteriorating communicative functioning. Hearing aids differ in price depending on factors such as brand reputation, payment plans, and return period (https://ibn.fm/seuXM). Hearing devices deploying innovative technology based on rigorous research and development can improve the performance of the devices and an overall user experience through features such as Bluetooth and smartphone apps, which can all affect the final price tag. Squaring the circle for the hearing aid devices, InnerScope Hearing Technologies is leading the way to deliver top quality direct-to-consumer, Bluetooth app-controlled hearing technology that is both affordable and convenient to get as it does not require patients to see a hearing professional or go to a hearing care clinic. The company continues to empower consumers to take control of their hearing health with its unique top-quality hearing aids, improving the quality of life of those who suffer from hearing impairment and hearing-related issues. With an aging population and an accompanying increase in the number of cases of age-related hearing loss, the addressable market for hearing aid devices is looking at strong growth potential. With innovative solutions that companies like InnerScope deliver, patients have access to hearing devices that are more discrete and affordable than ever before. InnerScope offers a full-service platform through its e-Commerce site (www.iHearDirect.com) and also collaborates with partners such as www.FSAstore.com, www.HSAstore.com, and www.WellDeservedHealth.com online platforms to serve consumers enrolled in flexible spending accounts, health saving accounts, and employers’ health incentive programs. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• U.S. House passes key cannabis bill to remove cannabis from federally banned substances
• A 2021 Pew Research Center poll indicates 91% of Americans agree that either medical or recreational cannabis use should be allowed
• HENC plans to expand into two states — Colorado and Massachusetts — that have legalized cannabis

For the second time, the U.S. House of Representatives has passed a bill designed to end the federal ban on marijuana, which a Reuters article says has “created legal headaches for users and businesses in the states that have legalized” the substance (https://ibn.fm/BL1Qk). The bill now heads to the Senate, where its fate is uncertain. Companies that operate in the cannabis space, including Hero Technologies (OTC: HENC), are watching closely. “The Marijuana Opportunity Reinvestment and Expungement [‘MORE’] Act, sponsored by Democratic Representative Jerrold Nadler of New York, which is in the process of legalizing the drug, removes marijuana from the list of controlled substances and eliminates criminal penalties for individuals who grow, distribute or possess it,” reported Reuters. “But the MORE act will need to gain 60 votes in the evenly divided Senate before moving to President Joe Biden’s desk for his signature.” The bill would “end decades of failed and unjust marijuana policy,” said Democratic Representative Ed Perlmutter. “It is clear prohibition is over. Today we have an opportunity to chart a new path forward on federal cannabis policy that actually makes sense.” Perlmutter noted that the bill will not force any state to legalize marijuana. The Reuters article stated that “marijuana users and businesses that sell it face a complicated legal patchwork in the U.S, where 37 states have legalized it in some form, either for recreation or medical use, while 13 still ban it entirely. Because federal law classifies cannabis as an illegal drug with no medical uses, researchers are severely limited in how they can study the drug and its impacts, making policy difficult to write. Cannabis businesses are also largely blocked from the U.S. banking system because of the federal ban.” The article noted that legalization of marijuana is extremely popular among Americans, with a 2021 Pew Research Center poll indicating that 91% agreed that either medical or recreational use should be allowed. Hero Technologies is a cannabis company working toward a vertically integrated business model with plans to expand into two states — Colorado and Massachusetts — that have legalized cannabis. HENC’s multistate model includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries. Currently, the company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Its Colorado expansion will come through its wholly owned subsidiary Mile High Green LLC, while expansion in Massachusetts is planned through another wholly owned subsidiary, MassCannabis LLC. For more information, visit the company’s website at www.HeroTechnologiesInc.com. NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC